Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
2 "Role"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
What We Talk about When We Talk about Caregiving: The Distribution of Roles in Cancer Patient Caregiving in a Family-Oriented Culture
Ansuk Jeong, Dongwook Shin, Jong Hyock Park, Keeho Park
Cancer Res Treat. 2019;51(1):141-149.   Published online March 21, 2018
DOI: https://doi.org/10.4143/crt.2017.557
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
When it comes to cancer care, the psychological well-being of family caregivers has gotten its deserved attention. However, the specific roles that the family caregivers take have not been examined as much. The current study aimed to investigate the distribution of family caregivers’ roles, particularly in a family-oriented culture, Korea.
Materials and Methods
A sample of 439 participants was recruited from 11 national and regional cancer centers in Korea. The participants who were 60 years old or above went through treatments for their gastric, colorectal, or lung cancer. The individual survey included questions regarding the family type, living arrangement, and the sources of support when it comes to their physical, emotional, financial, and decision-making needs.
Results
The responses from the participants showed that cancer caregiving is shared by multiple family caregivers; the major source of support for elderly cancer patients on diverse domains was their spouse; patients’ reliance on their daughter(s) increased for emotional support; and patients’ reliance on their son(s) stood out for financial support and decision-making support. Also, the older the patients were, the heavier their reliance was on the adult children, including sons, daughters, and daughters-in-law.
Conclusion
Future support programs for elderly cancer patients are suggested to involve multiple family caregivers to encourage effective and efficient intervention. Also, the limitations of the current study and the suggestions for future research are discussed.

Citations

Citations to this article as recorded by  
  • Exploring the Lived Experiences of Caregiving for Older Family Members by Young Caregivers in Singapore: Transition, Trials, and Tribulations
    Araviinthansai Subramaniam, Kalyani Kirtikar Mehta
    International Journal of Environmental Research and Public Health.2024; 21(2): 182.     CrossRef
  • Good Together Makes it Better?
    Carolina Blom, Ana Catarina Reis, Leonor Lencastre
    European Journal of Psychology Open.2024; 83(3): 119.     CrossRef
  • Caregiving Strain, family functioning, and effort to change diet for patients with gastrointestinal cancer: A cross-sectional descriptive study
    Myung Kyung Lee
    European Journal of Oncology Nursing.2023; 62: 102264.     CrossRef
  • Preferred and actual involvement of caregivers in oncologic treatment decision-making: A systematic review
    Laura M.L. Tielemans, Kirsten D. van Heugten, Marije E. Hamaker, Inez C. van Walree
    Journal of Geriatric Oncology.2023; 14(6): 101525.     CrossRef
  • Effectiveness of Nursing Interventions for Patients With Cancer and their Family Members: A Systematic Review
    Cristina Alfaro-Díaz, Erla Kolbrun Svavarsdottir, Nuria Esandi, Marianne E. Klinke, Ana Canga-Armayor
    Journal of Family Nursing.2022; 28(2): 95.     CrossRef
  • Active Engagement, Protective Buffering, and Depressive Symptoms in Young-Midlife Couples Surviving Cancer: The Roles of Age and Sex
    Karen S. Lyons, Jessica R. Gorman, Brandon S. Larkin, Grace Duncan, Brandon Hayes-Lattin
    Frontiers in Psychology.2022;[Epub]     CrossRef
  • Exploring positive experiences of primary and secondary caregivers of older persons in resource-limited urban settings in Accra, Ghana
    Frank Kyei-Arthur, Samuel Nii Ardey Codjoe, Delali Margaret Badasu, Vijayaprasad Gopichandran
    PLOS ONE.2022; 17(4): e0266269.     CrossRef
  • Health practices in Europe towards families of older patients with cancer: a scoping review
    Hanne Konradsen, Anne Brødsgaard, Birte Østergaard, Erla Svavarsdóttir, Karin B. Dieperink, Lorenz Imhof, Marie Louise Luttik, Romy Mahrer‐Imhof, Cristina García‐Vivar
    Scandinavian Journal of Caring Sciences.2021; 35(2): 375.     CrossRef
  • Family Caregivers' Emotional Preparedness for Death is Distinct from Their Cognitive Prognostic Awareness for Cancer Patients
    Siew Tzuh, Wen-Cheng Chang, Wen-Chi Chou, Chia-Hsun Hsieh, Jen-Shi Chen, Fur-Hsing Wen
    Journal of Palliative Medicine.2021; 24(3): 405.     CrossRef
  • Exploring perceptions and practices of cancer care among caregivers and care recipients of breast cancer in India
    Shradha S. Parsekar, Ajay Bailey, Binu V. S., Suma Nair
    Psycho-Oncology.2020; 29(4): 737.     CrossRef
  • 8,563 View
  • 183 Download
  • 11 Web of Science
  • 10 Crossref
Close layer
Frequency and Outcome of Neuroleptic Rotation in the Management of Delirium in Patients with Advanced Cancer
Seong Hoon Shin, David Hui, Gary Chisholm, Jung Hun Kang, Julio Allo, Janet Williams, Eduardo Bruera
Cancer Res Treat. 2015;47(3):399-405.   Published online November 24, 2014
DOI: https://doi.org/10.4143/crt.2013.229
AbstractAbstract PDFPubReaderePub
Purpose
The response to haloperidol as a first-line neuroleptic and the pattern of neuroleptic rotation after haloperidol failure have not been well defined in palliative care. The purpose of this study was to determine the efficacy of haloperidol as a first-line neuroleptic and the predictors associated with the need to rotate to a second neuroleptic. Materials and Methods We conducted a retrospective review of the charts of advanced cancer patients admitted to our acute palliative care unit between January 2012 and March 2013. Inclusion criteria were a diagnosis of delirium and first-line treatment with haloperidol. Results Among 167 patients with delirium, 128 (77%) received only haloperidol and 39 (23%) received a second neuroleptic. Ninety-one patients (71%) who received haloperidol alone improved and were discharged alive. The median initial haloperidol dose was 5 mg (interquartile ranges [IQR], 3 to 7 mg) and the median duration was 5 days (IQR, 3 to 7 days). The median final haloperidol dose was 6 mg (IQR, 5 to 7 mg). A lack of treatment efficacy was the most common reason for neuroleptic rotation (87%). Significant factors associated with neuroleptic rotation were inpatient mortality (59% vs. 29%, p=0.001), and being Caucasian (87% vs. 62%, p=0.014). Chlorpromazine was administered to 37 patients (95%) who were not treated successfully by haloperidol. The median initial chlorpromazine dose was 150 mg (IQR, 100 to 150 mg) and the median duration was 3 days (IQR, 2 to 6 days). Thirteen patients (33%) showed reduced symptoms after the second neuroleptic. Conclusion Neuroleptic rotation from haloperidol was only required in 23% of patients with delirium and was associated with inpatient mortality and white race.

Citations

Citations to this article as recorded by  
  • Naming racism as a root cause of inequities in palliative care research: a scoping review
    Kavita Algu, Joshua Wales, Michael Anderson, Mariam Omilabu, Thandi Briggs, Allison M. Kurahashi
    BMC Palliative Care.2024;[Epub]     CrossRef
  • Management of Physical Symptoms in Patients with Advanced Cancer during the Last Weeks and Days of Life
    Ahsan Azhar, David Hui
    Cancer Research and Treatment.2022; 54(3): 661.     CrossRef
  • Chlorpromazine as Treatment for Refractory Agitation Associated with Pediatric Delirium
    Shin Young Kim, Shari Simone, Omayma A. Kishk, Ana Lia Graciano, Hyunuk Seung, Sarah Edwards
    The Journal of Pediatric Pharmacology and Therapeutics.2022; 27(8): 725.     CrossRef
  • Pharmacological and non-pharmacological treatment of delirium in an oncological hospital service: an integrative review
    Luciana Aparecida Vieira Louro, João Francisco Possari, Antônio Fernandes Costa Lima
    Revista Brasileira de Enfermagem.2021;[Epub]     CrossRef
  • Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial
    David Hui, Allison De La Rosa, Annie Wilson, Thuc Nguyen, Jimin Wu, Marvin Delgado-Guay, Ahsan Azhar, Joseph Arthur, Daniel Epner, Ali Haider, Maxine De La Cruz, Yvonne Heung, Kimberson Tanco, Shalini Dalal, Akhila Reddy, Janet Williams, Sapna Amin, Terri
    The Lancet Oncology.2020; 21(7): 989.     CrossRef
  • A Scoping Review to Map Empirical Evidence Regarding Key Domains and Questions in the Clinical Pathway of Delirium in Palliative Care
    Peter G. Lawlor, Nicole A. Rutkowski, Alistair R. MacDonald, Mohammed T. Ansari, Lindsey Sikora, Franco Momoli, Salmaan Kanji, David K. Wright, Erin Rosenberg, Annmarie Hosie, Jose L. Pereira, David Meagher, Jill Rice, John Scott, Shirley H. Bush
    Journal of Pain and Symptom Management.2019; 57(3): 661.     CrossRef
  • Prevalencia de delirium mediante la escala Memorial Delirium Assessment Scale (MDAS) en pacientes oncológicos avanzados ingresados en una Unidad de Cuidados Paliativos. Factores de riesgo, reversibilidad y tratamiento recibido
    Verónica Díaz García, Miriam López Pérez, Yolanda Zuriarrain Reyna
    Medicina Paliativa.2018; 25(4): 245.     CrossRef
  • Clinical Assessment and Management of Delirium in the Palliative Care Setting
    Shirley Harvey Bush, Sallyanne Tierney, Peter Gerard Lawlor
    Drugs.2017; 77(15): 1623.     CrossRef
  • Delirium Management: Diagnosis, Assessment, and Treatment in Palliative Care
    Min Seok Seo, Yong Joo Lee
    The Korean Journal of Hospice and Palliative Care.2016; 19(3): 201.     CrossRef
  • Neuroleptics in the management of delirium in patients with advanced cancer
    David Hui, Rony Dev, Eduardo Bruera
    Current Opinion in Supportive & Palliative Care.2016; 10(4): 316.     CrossRef
  • Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: A prospective observational study
    David Hui, Renata dos Santos, Suresh Reddy, Maria Salete de Angelis Nascimento, Donna S Zhukovsky, Carlos Eduardo Paiva, Shalini Dalal, Everaldo Donizeti Costa, Paul Walker, Heloisa Helena Scapulatempo, Rony Dev, Camila Souza Crovador, Maxine De La Cruz,
    Palliative Medicine.2015; 29(9): 826.     CrossRef
  • 12,434 View
  • 98 Download
  • 12 Web of Science
  • 11 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP